Binding properties of an orally active platinum anti-tumor drug JM216 with metallothionein in vivo

By Xing B.  

BioMetals, Vol. 13, Iss. 3, 2000-09 ,pp. : 203-208

Springer Publishing Company

Access to resources Recommend Favorite

Borato-1,2-diaminocyclohexane Platinum (II), a Novel Anti-Tumor Drug

By Dibas A.   Howard J.   Anwar S.   Stewart D.   Khan A.  

Biochemical and Biophysical Research Communications, Vol. 270, Iss. 2, 2000-04 ,pp. : 383-386

Elsevier

Access to resources Recommend Favorite

In vitro metabolism of an orally active O -methyl amidoxime prodrug for the treatment of CNS trypanosomiasis

By Ansede J. H   Voyksner R. D   Ismail M. A   Boykin D. W   Tidwell R. R   Hall J. E  

Xenobiotica, Vol. 35, Iss. 3, 2005-03 ,pp. : 211-226

Informa Healthcare

Access to resources Recommend Favorite

A quantitative structure-activity relationship study of novel, potent, orally active, selective VEGFR-2 and PDGFRα tyrosine kinase inhibitors: Derivatives of N-Phenyl-N'-{4-(4-quinolyloxy)phenyl}urea as antitumor agents

By Sharma B. K.   Sharma S. K.   Singh P.   Sharma Susheela  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 23, Iss. 2, 2007-06 ,pp. : 168-173

Informa Healthcare

Access to resources Recommend Favorite

Synthesis, characterization, and in vitro antitumor properties of gold(III) compounds with the traditional Chinese medicine (TCM) active ingredient liriodenine

By Chen Zhen-Feng   Liu Yan-Cheng   Peng Yan   Hong Xue   Wang Hong-Hong   Zhang Min-Min   Liang Hong  

JBIC Journal of Biological Inorganic Chemistry, Vol. 17, Iss. 2, 2012-02 ,pp. : 247-261

Springer Publishing Company

Access to resources Recommend Favorite